| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/01/2003 | WO2002048148A3 Pyrazolopyridine derivatives |
| 05/01/2003 | WO2002046158A9 Piperidine/piperazine-type inhibitors of p38 kinase |
| 05/01/2003 | WO2002012442A3 Heterocyclic compounds as ligands of the gabaa receptor |
| 05/01/2003 | US20030083500 Imidazonaphthyridines |
| 05/01/2003 | US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment |
| 05/01/2003 | US20030083230 Reversal of multidrug resistance in human colon carcinoma cells |
| 05/01/2003 | US20030082830 Compound for use as diagnostic and therapeutic tools in medicine and science |
| 05/01/2003 | US20030079311 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
| 05/01/2003 | CA2464981A1 Quinoline compound |
| 05/01/2003 | CA2464593A1 6-hydroxy isoflavones, derivatives and medicaments involving same |
| 05/01/2003 | CA2463975A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 05/01/2003 | CA2463311A1 Androgen receptor modulators and methods of use thereof |
| 05/01/2003 | CA2461545A1 Drugs comprising combination of triazaspiro¬5,5|undecane derivative with cytochrome p450 isozyme 3a4 inhibitor and/or p-glycoprotein inhibitor |
| 05/01/2003 | CA2461159A1 Imidazopyridine compounds as 5-ht4 receptor modulators |
| 05/01/2003 | CA2460680A1 Substituted indazole compounds for the treatment of inflammation |
| 04/30/2003 | CN1414966A Process and intermediates for preparation of imidazolidinone alpha U protein antagonists |
| 04/30/2003 | CN1414964A Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 04/30/2003 | CN1414960A Substituted piperidines, medicaments containing these compounds, and methods for production thereof |
| 04/30/2003 | CN1414952A Heterocyclic compounds having sulfonic acid |
| 04/30/2003 | CN1414848A Prevention of plaque rupure by ACAT inhibitors |
| 04/30/2003 | CN1414847A Sustained-releasing antihelmintic compositions comprising praziquantel |
| 04/30/2003 | CN1413988A Substituted transannular tetracarboxylic acid diimide |
| 04/30/2003 | CN1107069C Derivatives of camptothecin for use in treating cancer and its use |
| 04/30/2003 | CN1107066C Diaza-spiro [3,5] nonane derivatives |
| 04/29/2003 | US6555959 For high luminance of orange to red light; for filter dye or color filter in photography; low voltage |
| 04/29/2003 | US6555688 Method for the production of triethylene diamine making use of ethylene diamine |
| 04/29/2003 | US6555567 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides |
| 04/29/2003 | US6555550 Musarinic agonists and antagonists |
| 04/29/2003 | US6555548 Administering therapeutically effective amount of active agent selected from the group consisting of a heterocyclic amine-type compound, a substituted phenylazacycloalkane-type compound, and a cabergoline-type compound, and their salts |
| 04/29/2003 | US6555544 9-hydroxyrisperidone palmitate ester having a surfactant adsorbed to the surface thereof; for administration via intramuscular or subcutaneous injection; treating psychological and neurodegenerative disorders |
| 04/29/2003 | US6555542 Sulfonamide lactam inhibitors of FXa and method |
| 04/29/2003 | US6555539 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
| 04/29/2003 | US6555538 Respiratory system disorders; antiarthritic agents; psychological disorders; nervous system disorders |
| 04/29/2003 | CA2227513C New ellipticine derivatives, their preparation process and the pharmaceutical compositions containing them |
| 04/24/2003 | WO2003033502A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/24/2003 | WO2003033496A1 Beta-carbolin derivatives as ptp-inhibitors |
| 04/24/2003 | WO2003033478A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
| 04/24/2003 | WO2003033477A1 Alkynlated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitor |
| 04/24/2003 | WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 04/24/2003 | WO2003032989A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/24/2003 | WO2003032984A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 04/24/2003 | WO2003032962A2 Dual action antibiotics |
| 04/24/2003 | WO2002068406A3 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 04/24/2003 | WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030078426 Thiazolidine or oxazolidine compounds useful for preventing or therapeutical agents for various diseases such as diabetes and hyperlipemia |
| 04/24/2003 | US20030078425 N-oxyl compound contained in an easily polymerizable material can be sufficiently decreased and loss of easily polymerizable material (acrylic or methacrylic acids or their esters) is little |
| 04/24/2003 | US20030078419 For therapy of autoimmune diseases mediated by cathepsin S; for inhibiting the progression of tissue transplant rejection |
| 04/24/2003 | US20030078416 Substituted phenanthrolines |
| 04/24/2003 | US20030078280 Macroheterocylic compounds useful as kinase inhibitors |
| 04/24/2003 | US20030078279 For therapy and prophylaxis of pain, central nervous system disorder or the like in mammalian subjects |
| 04/24/2003 | US20030078278 Spiropiperidine compounds as ligands for ORL-1 receptor |
| 04/24/2003 | US20030078277 For therapy and prophylaxis of depression; Tourette syndrome, autism, bipolar disorder, cyclothymia, schizophrenia, Alzheimer disease, obesity, diabetes, alcohol dependence, sleep disorder, insomnia, migraine, stress headache, etc. |
| 04/24/2003 | US20030078276 Matrix metalloproteinase inhibitors |
| 04/24/2003 | US20030078275 For therapy of cancer, diabetes and Alzheimer's disease |
| 04/24/2003 | US20030078274 Method of reducing neuronal injury or apoptosis |
| 04/24/2003 | US20030078254 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | CA2463159A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
| 04/24/2003 | CA2462441A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/24/2003 | CA2462147A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/23/2003 | EP1304110A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/23/2003 | EP1303641A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 04/23/2003 | EP1303519A1 Tricyclic imidazopyridines |
| 04/23/2003 | EP1303515A2 Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors |
| 04/23/2003 | EP1303282A1 Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides |
| 04/23/2003 | EP1257537A4 Therapeutic morpholino-substituted compounds |
| 04/23/2003 | EP1218378B1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/23/2003 | EP1063230B1 Cyclic amino compounds |
| 04/23/2003 | EP1035848B1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels |
| 04/23/2003 | EP0910379B1 Plaster for the transdermal application of pergolide |
| 04/23/2003 | CN1413216A Azolyalkyl-oxa (di) azolyl pyri (mi) dine derivatives, method for their production and use as pesticides |
| 04/23/2003 | CN1413213A Azaindoles |
| 04/23/2003 | CN1413212A Process for preparation of 6-methyl-2-(4-methyl-phenyl)-imidazo [1,2-a] pyrimidine-3-(N,N-dimethyl-acetamide) and intermediates |
| 04/23/2003 | CN1413211A Substituted 1,3,4-oxadiazoles and method of producing TNF-alpha levels |
| 04/23/2003 | CN1413207A 5-membered ring heterocyclic compounds with nitrogen |
| 04/23/2003 | CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
| 04/22/2003 | US6552198 Adding such as lactic acid, placing in well closed container, evacuating and sealing |
| 04/22/2003 | US6552189 Anhydrous mirtazapine crystals and process for preparing the same |
| 04/22/2003 | US6552073 Compounds and methods of treating cell proliferative diseases |
| 04/22/2003 | US6552065 Antiproliferative agents |
| 04/22/2003 | US6552037 An imidazo(1,2-a)Pyridine compound useful for altering the signal-transducing activity of gamma-aminobuytric acid receptor |
| 04/22/2003 | US6552033 Imidazo-containing heterocyclic compounds, their compositions and uses |
| 04/22/2003 | US6552021 Antitumor agent |
| 04/22/2003 | US6552018 As antitumor agents |
| 04/22/2003 | US6552017 Substituted heterocycle fused gamma-carbolines |
| 04/22/2003 | US6552015 Azabicycloalkane derivatives and therapeutic uses thereof |
| 04/22/2003 | US6552012 Heteroaryl diazabicycloalkanes, their preparation and use |
| 04/22/2003 | CA2287054C 1,3,8-triazaspiro¬4,5|decanone compounds as orl1-receptor agonists |
| 04/22/2003 | CA2239187C Inhibitors of farnesyl protein transferase |
| 04/17/2003 | WO2003031452A2 4-haloethenylphenyl tropane:serotonin transporter imaging agents |
| 04/17/2003 | WO2003031446A1 Imidazo-pyridine derivatives for use in the treatment of herpes viral infection |
| 04/17/2003 | WO2003031445A1 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists |
| 04/17/2003 | WO2003031444A1 Polycyclic compounds having anti-tumor activity |
| 04/17/2003 | WO2003031443A1 Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety |
| 04/17/2003 | WO2003031441A1 Multiple action compounds |
| 04/17/2003 | WO2003031439A1 Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole |
| 04/17/2003 | WO2003031436A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 04/17/2003 | WO2003031435A1 Pyrazole derivatives as glycine transporter inhibitors |
| 04/17/2003 | WO2003031397A1 Acylsulfonamides as inhibitors of steroid sulfatase |